|4Oct 26, 7:39 PM ET

Happel David 4

4 · Horizon Pharma plc · Filed Oct 26, 2017

Insider Transaction Report

Form 4
Period: 2017-10-25
Happel David
EVP Global Orphan Bus. Unit
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2017-10-257,95323,860 total
    Ordinary Shares (7,953 underlying)
  • Tax Payment

    Ordinary Shares

    2017-10-25$13.53/sh4,150$56,1505,089 total
  • Exercise/Conversion

    Ordinary Shares

    2017-10-25+7,9539,239 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]Includes 1,286 ordinary shares of the Issuer acquired by the reporting person on June 1, 2017 pursuant to an employee stock purchase program.
  • [F3]On October 25, 2016, the reporting person was granted an aggregate of 31,813 restricted stock units. The restricted stock units vest in four equal annual installments beginning on October 25, 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION